Cargando…
How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
BACKGROUND: Migraine is a major public health issue associated with significant morbidity, considerable negative impact on quality of life, and significant socioeconomic burden. Preventive treatments are required to reduce the occurrence and the severity of acute attacks and to minimize the use of a...
Autores principales: | Tiseo, Cindy, Ornello, Raffaele, Pistoia, Francesca, Sacco, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734464/ https://www.ncbi.nlm.nih.gov/pubmed/31060490 http://dx.doi.org/10.1186/s10194-019-1000-5 |
Ejemplares similares
-
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
por: De Matteis, Eleonora, et al.
Publicado: (2022) -
O050. Chronic daily headache and body mass index: a meta-analysis of observational studies
por: Tiseo, Cindy, et al.
Publicado: (2015) -
Migraine and body mass index categories: a systematic review and meta-analysis of observational studies
por: Ornello, Raffaele, et al.
Publicado: (2015) -
O032. Associations between any headache and obesity: results from a systematic review and meta-analysis of observational studies
por: Degan, Diana, et al.
Publicado: (2015) -
The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
por: Ornello, Raffaele, et al.
Publicado: (2019)